| Value | ₹3,000 Cr |
|---|
BSE filing, NSE: PFOCUS. Summary written from the filing by ALFA Finder's alert engine.
Prime Focus Ltd: key numbers
- Share price
- ₹288.10
- Market cap
- ₹22,436 Cr
- Revenue (annual)
- ₹4,676 Cr
- Net profit (annual)
- ₹218.7 Cr
- P/E (TTM)
- 148.7×Sector 28.1×
- Promoter holding
- 60.55%-0.18% QoQ
- FII holding
- 2.97%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Prime Focus Ltd
All →Prime Focus Other Announcement
Prime Focus Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Prime Focus Annual General Meeting
Prime Focus Limited convened an Extraordinary General Meeting for Nov 7, 2026. Agenda items include approving material related party transactions valued at Rs. 265.67 Crore.
- Value
- ₹265.7 Cr
Prime Focus Annual General Meeting
Prime Focus Limited has scheduled an Extra-Ordinary General Meeting (EOGM) for November 07, 2026, to be held via video conferencing to approve various related party transactions.
Prime Focus ED Probe / Tax Survey
Prime Focus confirmed an ongoing Income Tax Department search at its Mumbai offices on 7 Oct 2026. No findings or demands received; operations continue unaffected.
Prime Focus Merger & Restructuring
Prime Focus Limited's shareholders approved the previously announced transfer of its subsidiary, Prime Focus Technologies Inc., to DNEG S.a.r.l. at the recent AGM.
Prime Focus Capital Structure Change
Prime Focus Limited shareholders approved increasing the authorized share capital to Rs. 100 Crore at the AGM. The expansion from 85 Crore shares supports future capital raising through equity or debt.
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.